Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROactive Evaluation of Function to Avoid CardioToxicity

NCT03862131 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT03862131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03862131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROactive Evaluation of Function to Avoid CardioToxicity
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Terminated
Start date
March 13, 2019
Completion date
June 14, 2024
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cardiotoxicity, leukemia, lung cancer, lymphoma, myeloma, sarcoma